SEC Form 4 · accession 0001664281-26-000004
Entrada Therapeutics, Inc. · TRDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kush Parmar
Director
Period of report
Aug 6, 2026
Accepted (ET)
Aug 10, 2026 · 7:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001689375
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 6, 2026 | S | 10,494 | $7.00 | D | 2,836,098 | I | By 5AM Ventures V, L.P. |
| Common StockF3 | Aug 7, 2026 | S | 52,317 | $6.85 | D | 2,783,781 | I | By 5AM Ventures V, L.P. |
| Common StockF4,F2 | Aug 10, 2026 | S | 92,444 | $7.00 | D | 2,691,337 | I | By 5AM Ventures V, L.P. |
| Common StockF5 | holding | — | — | — | 1,093,313 | I | By 5AM Opportunities I, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.90 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Kush M. Parmar, M.D., Ph.D. is a managing member of 5AM Partners and may be deemed to share voting and investment power over the shares held by 5AM V. Dr. Parmar disclaims beneficial ownership of the shares held by 5AM V except to the extent of his pecuniary interest therein.
- F3The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.80 to $7.01 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F4The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.84 to $7.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F5Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Kush M. Parmar, M.D., Ph.D. is a managing member of Opportunities GP and may be deemed to share voting and investment power over the shares held by Opportunities. Dr. Parmar disclaims beneficial ownership of the shares held by Opportunities except to the extent of his pecuniary interest therein.